Brainstorm Cell Therapeutics | BCLI - Despesas De Vendas E Administração





Despesas De Vendas E Administração Alterar Data
Alterity Therapeutics Limited AUD 1.45M 703.96K 2025-12
Biogen USD 752M 42.3M 2026-09
Brainstorm Cell Therapeutics USD 1.21M 178K 2026-03
Cipla INR 13.25B 101.8M 2025-12
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.44M 5K 2026-06
CSL USD 1.23B 498M 2025-12
Cytokinetics USD 113.14M 8.75M 2026-09
Gilead Sciences USD 1.52B 70M 2026-06
Grifols EUR 320.45M 12.65M 2025-12
Halozyme Therapeutics USD 58.24M 1.24M 2026-09
Mesoblast USD 85.89M 57.35M 2026-06